COVID-19 managed with early non-invasive ventilation and a bundle pharmacotherapy: A case report

作者：Mian Peng, Di Ren, Xueyan Liu, Jinxiu Li, Ronglin Chen, Baojun Yu, Yongfeng Liu, Xi Meng, Yansi Lyu · 发表于：World Journal of Clinical Cases · 年份：2020 · DOI：10.12998/wjcc.v8.i9.1705 · 被引用次数：6 · 研究领域：COVID-19 Clinical Research Studies、Respiratory Support and Mechanisms、Long-Term Effects of COVID-19

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has become an immense public health burden, first in China and subsequently worldwide. Developing effective control measures for COVID-19, especially measures that can halt the worsening of severe cases to a critical status is of urgent importance. CASE SUMMARY: /L (60.6 ± 2.67% neutrophils and 30.4 ± 1.34% lymphocytes). Chest imaging revealed bilateral ground-glass lung changes. Based on a positive nasopharyngeal swab nucleic acid test result and clinical characteristics, the patient was diagnosed with COVID-19. Following treatment with early non-invasive ventilation and a bundle pharmacotherapy, she recovered with a good outcome. CONCLUSION: Early non-invasive ventilation with a bundle pharmacotherapy may be an effective treatment regimen for the broader population of patients with COVID-19.